Co-Authors
This is a "connection" page, showing publications co-authored by PADMANEE SHARMA and ASIF RASHID.
Connection Strength
0.268
-
Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial. Lancet Gastroenterol Hepatol. 2022 03; 7(3):208-218.
Score: 0.206
-
Tissue and imaging biomarkers of response to neoadjuvant nivolumab or nivolumab plus ipilimumab in patients with resectable hepatocellular carcinoma. Oncology. 2024 Oct 18; 1-20.
Score: 0.062